Press Release

Analysis of Nuclear Medicine Radioisotopes Market 2019-2024: Industry Trends, Share, Size, Price, Revenue, Business Strategy, Production Technology Forecast to 2024

Nuclear

The “Nuclear Medicine Radioisotopes Market” research report 2019-2024 delivers comprehensive information and valuable insights about the Nuclear Medicine Radioisotopes industry. The information available in the Nuclear Medicine Radioisotopes market report is not only based on the facts but also on the case studies, which analysts have included to convey appropriate information to the clients in a well-versed manner. Nuclear Medicine Radioisotopes market report includes valuable information to assist new entrants, as well as established players, to understand the prevailing trends in the market.

Some Companies Are Covered in the Nuclear Medicine Radioisotopes Market:

  • Agfa
  • Gevaert Group
  • Cardiarc Ltd
  • Digirad Corporation
  • CMR Naviscan (Gamma Medica Inc.)
  • GE Healthcare
  • Positron Corp.
  • Segami Corporation
  • Siemens Healthcare GmBH
  • Nordion (Canada) Inc.
  • NTP Radioisotopes SOC Ltd
  • Bracco S.p.A
  • Cardinal Health Inc.
  • Curium

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/13999554

    Market Overview:

  • Increasing cases of cancer and cardiac ailments are the major drivers for the nuclear medicines radioisotopes market. Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics. They meet the statutory definition of drugs under Section 1861(t) of the Social Security Act because they either are included in the various drug compendia or recognized by hospital medical staff as drugs. Historically, nuclear medicine has been well established as a therapeutic modality for thyroid cancer, Graves’ disease, hyperthyroidism, and bone pain palliation, associated with skeletal metastasis. Hence, the broadening applications of radioisotopes are expected to propel market growth.

    Scope of the Report:

  • As per the , medical radioisotopes are defined as safe radioactive substances that are primarily used in the diagnosis of medical conditions. These radioisotopes, used in a diagnosis, emit gamma rays of energy that are sufficient to escape from the body. The rays also have a short half-life, which is apt, since the rays can decay as soon as the imaging is completed.

    Reasons for Buying Nuclear Medicine Radioisotopes Market Report:

    • This report provides pin-point analysis for changing competitive dynamics
    • It provides a forward looking perspective on different factors driving or restraining market growth
    • It provides a five-year forecast assessed on the basis of how the market is predicted to grow
    • It helps in understanding the key product segments and their future
    • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
    • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/13999554

    Key Market Trends:

    Oncology Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period

    Radiotherapy can be used to treat various medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. PET, which is a precise technique, uses isotopes produced in a cyclotron. It is highly used for a clinical role in oncology, with fluorine-18 as the tracer, and is proven to be the most accurate non-invasive method of detecting and evaluating most cancers. A new field for cancer treatment is targeted alpha therapy (TAT) or alpha radio-immunotherapy, especially for the control of dispersed cancers. Nuclear medicine is proven effective in oncology in several roles, spanning the course of the disease, including the characterization of a mass, staging, restaging, and monitoring of therapeutic response. Hence, owing to these associated factors, the oncology segment is expected to exhibit the fastest growth rate.

    North America captured the Largest Market Share and is Expected to Retain its Dominance

    North America captured the largest market share in the nuclear medicine radioisotopes market. The United States was the largest contributor to the revenue of North America, and is expected to retain its dominance owing to the higher procedural volume and increasing adoption of the nuclear medicine isotopes for various therapeutic applications. Bone scintigraphy is the next most common nuclear medicine procedure performed in the United States, but it represents only 17% of procedures. The volume of PET procedures in the United States is approximately 1.5 million per year. Oncology accounts for more than 90% of the PET and PET/CT procedures performed, whereas cardiology and neurology account for about 4% each. Canada is the largest producer of Technetium-99m. Due to the use of Tc-99m in radiopharmaceuticals, the market is expected to grow at a tremendous rate in Canada. 80% of the nuclear medicine market is driven by Tc-99m in various diagnostic procedures and treatments. Considering these factors associated with the United States and Canada, the North American market is expected to experience accelerated growth rates and market dominance.

    Nuclear Medicine Radioisotopes Market Report Provides Comprehensive Analysis of:

    • Functional market industry outline
    • Up and downstream industry examination
    • Channels and propositions believability
    • Market challenge by key players
    • Enhancement suggestions examination

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/13999554

    Report Highlights:

    • Market Dynamics – Drivers, Restraints, and Opportunities
    • Market Segmentation – Types, Applications, Regions, and Technology
    • Market Trends
    • Competitive Landscape
    • SWOT Analysis and Porter’s Five Forces Analysis

    Detailed TOC of Nuclear Medicine Radioisotopes Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Rising Incidences of Cancer and Cardiac Disorders
    4.2.2 Widening Applications of Nuclear Medicine
    4.2.3 Increasing SPECT and PET Applications
    4.2.4 Increasing Patient Awareness for Healthcare
    4.3 Market Restraints
    4.3.1 Reimbursement Complications
    4.3.2 Regulatory Issues
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 Type of Radioisotopes
    5.1.1 Technetium-99m (Tc-99m)
    5.1.2 Thallium-201 (Tl-201)
    5.1.3 Iodine (I-123)
    5.1.4 Fluorine-18
    5.1.5 Rubidium-82 (Rb-82)
    5.1.6 Iodine-131 (I-131)
    5.1.7 Lutetium-177 (Lu-177)
    5.1.8 Radium-223 (Ra-223) & Alpharadin
    5.1.9 Actinium-225 (Ac-225)
    5.1.10 Others
    5.2 Application
    5.2.1 Oncology
    5.2.2 Cardiology
    5.2.3 Lymphoma
    5.2.4 Thyroid
    5.2.5 Neurology
    5.2.6 Other Applications
    5.3 Geography
    5.3.1 North America
    5.3.1.1 United States
    5.3.1.2 Canada
    5.3.1.3 Mexico
    5.3.2 Europe
    5.3.2.1 Germany
    5.3.2.2 United Kingdom
    5.3.2.3 France
    5.3.2.4 Italy
    5.3.2.5 Spain
    5.3.2.6 Rest of Europe
    5.3.3 Asia-Pacific
    5.3.3.1 China
    5.3.3.2 Japan
    5.3.3.3 India
    5.3.3.4 Australia
    5.3.3.5 South Korea
    5.3.3.6 Rest of Asia-Pacific
    5.3.4 Rest of the World

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Agfa-Gevaert Group
    6.1.2 Cardiarc Ltd
    6.1.3 Digirad Corporation
    6.1.4 CMR Naviscan (Gamma Medica Inc.)
    6.1.5 GE Healthcare
    6.1.6 Positron Corp.
    6.1.7 Segami Corporation
    6.1.8 Siemens Healthcare GmBH
    6.1.9 Nordion (Canada) Inc.
    6.1.10 NTP Radioisotopes SOC Ltd
    6.1.11 Bracco S.p.A
    6.1.12 Cardinal Health Inc.
    6.1.13 Curium

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Military Boots Market 2019 | Worldwide Industry Trends, Share, Gross Margin, Size, Future Demand, Analysis by Top Leading Player and Forecast till 2024

    Hemato Oncology Testing Market 2019 Global Industry Forecasts Analysis, Company Profiles, Competitive Landscape and Key Regions Analysis Available at Industry Research Biz

    Air Knife Market 2019 Types and Applications, Market Share, Size, Industry and Development Trend 2024

    Special and Extruded Graphite Industry 2019 | Global Market Size, Share, Revenue, Emerging Trends of Top Companies, and Development Forecast to 2023

    Tags
  • Alfredoo Epps

    Alfredo Epps is a finance expert heading the petroleum column. He joined the group last year as an associate writer. But his thorough research skills and ability to seamlessly putting numerical data into words helped him get a senior position. Apart from a column head, Alfredo is a dancer and a violinist.

    Related Articles

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    Close